BR112016008055A2 - Proteínas com usos diagnósticos e terapêuticos - Google Patents
Proteínas com usos diagnósticos e terapêuticosInfo
- Publication number
- BR112016008055A2 BR112016008055A2 BR112016008055A BR112016008055A BR112016008055A2 BR 112016008055 A2 BR112016008055 A2 BR 112016008055A2 BR 112016008055 A BR112016008055 A BR 112016008055A BR 112016008055 A BR112016008055 A BR 112016008055A BR 112016008055 A2 BR112016008055 A2 BR 112016008055A2
- Authority
- BR
- Brazil
- Prior art keywords
- diagnostic
- proteins
- therapeutic uses
- csf
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
- G01N2333/3156—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
Abstract
PROTEÍNAS COM USOS DIAGNÓSTICO SE TERAPÊUTICOS A presente invenção está relacionada a uma proteína recombinante capaz de ligar - se ao fator H do complemento (FHC), induzindo assim ligação aumentada a C3d e C3b por FHC ligado comparado com FHC não ligado. São também descritos métodos e dispositivos médicos para uso da mesma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1318170.6A GB201318170D0 (en) | 2013-10-14 | 2013-10-14 | Proteins with Diagnostic and Therapeutic Uses |
PCT/GB2014/053072 WO2015055991A1 (en) | 2013-10-14 | 2014-10-13 | Proteins with diagnostic and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016008055A2 true BR112016008055A2 (pt) | 2017-10-03 |
Family
ID=49680023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016008055A BR112016008055A2 (pt) | 2013-10-14 | 2014-10-13 | Proteínas com usos diagnósticos e terapêuticos |
Country Status (11)
Country | Link |
---|---|
US (4) | US10035827B2 (pt) |
EP (2) | EP3057979B1 (pt) |
JP (3) | JP6691042B2 (pt) |
CN (3) | CN114031676A (pt) |
AU (3) | AU2014335925B2 (pt) |
BR (1) | BR112016008055A2 (pt) |
CA (1) | CA2925663A1 (pt) |
DK (1) | DK3057979T3 (pt) |
ES (1) | ES2800599T3 (pt) |
GB (1) | GB201318170D0 (pt) |
WO (1) | WO2015055991A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
US20190071477A1 (en) * | 2015-12-31 | 2019-03-07 | Quassia Biopharma Co., Ltd | Recombinant complement Factor H-immunoglobulin fusion protein with complement regulatory activity, and preparation method therefor and use thereof |
GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
MX2022000725A (es) * | 2019-07-17 | 2022-04-26 | Gemini Therapeutics Sub Inc | Anticuerpos potenciadores del factor h y usos de estos. |
EP4001301A1 (en) * | 2020-11-13 | 2022-05-25 | Navigo Proteins Gmbh | Binding protein for complement factor h (cfh) |
GB202102931D0 (en) | 2021-03-02 | 2021-04-14 | Invizius Ltd | Peritoneal fluid composition |
GB202202728D0 (en) | 2022-02-28 | 2022-04-13 | Invizius Ltd | Peritoneal fluid composition |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
CH680045A5 (pt) * | 1990-02-16 | 1992-06-15 | Om Lab Sa | |
US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
EP0885965A3 (en) * | 1997-06-20 | 2000-01-12 | Smithkline Beecham Corporation | Histidine kinase polypeptides |
US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
EP1067962B1 (en) * | 1998-04-07 | 2010-03-24 | MedImmune, LLC | Derivatives of pneumococcal choline binding proteins for vaccines |
US20010016200A1 (en) * | 1998-04-23 | 2001-08-23 | Briles David E. | Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
JP2002516251A (ja) * | 1998-04-23 | 2002-06-04 | ユーエイビー リサーチ ファンデーション | 肺炎球菌表面プロテインC(PspC)のエピトープ領域およびその菌株選択、ならびにそのための使用法 |
GB9816337D0 (en) * | 1998-07-27 | 1998-09-23 | Cortecs Uk Ltd | Proteins |
KR20080039550A (ko) | 1999-05-07 | 2008-05-07 | 제넨테크, 인크. | B 세포 표면 마커에 결합하는 길항물질을 이용한 자가면역질환의 치료 |
WO2000076541A1 (en) * | 1999-06-10 | 2000-12-21 | Uab Research Foundation | Pneumococcal surface protein combination vaccine |
WO2002008426A2 (en) | 2000-07-20 | 2002-01-31 | Hansa Medical Ab | Fh-binding protein of streptococcus pneumoniae |
EP1301602A2 (en) | 2000-07-20 | 2003-04-16 | Hansa Medical AB | Fh-binding protein of streptococcus pneumoniae |
US6957392B2 (en) * | 2002-01-16 | 2005-10-18 | Laszlo Systems, Inc. | Interface engine providing a continuous user interface |
DE10258924A1 (de) * | 2002-12-17 | 2004-07-08 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Mit die Adhäsion von biologischem Material vermittelnden Substanzen beschichtete Vorrichtung |
WO2006130328A2 (en) * | 2005-05-13 | 2006-12-07 | Novartis Vaccines And Diagnostics, Inc. | Serum resistance factors of gram positive bacteria |
PL1843375T3 (pl) * | 2006-04-05 | 2011-12-30 | Abb Technology Ag | Urządzenie uruchamiające elektromagnetyczne, zwłaszcza dla przełącznika napięcia średniego |
DE102010001914A1 (de) * | 2010-02-15 | 2011-08-18 | Robert Bosch GmbH, 70469 | Lenkvorrichtung für ein Kraftfahrzeug |
WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
WO2012087925A1 (en) * | 2010-12-20 | 2012-06-28 | The Trustees Of The University Of Pennsylvania | Factor h binding peptides and uses thereof |
WO2012134975A1 (en) * | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
WO2015025856A1 (ja) | 2013-08-21 | 2015-02-26 | 国立大学法人大阪大学 | 標的物質とリガンドとの結合親和性を測定するための方法、ならびに該方法に使用するための試薬助剤およびキット |
-
2013
- 2013-10-14 GB GBGB1318170.6A patent/GB201318170D0/en not_active Ceased
-
2014
- 2014-10-13 EP EP14789350.7A patent/EP3057979B1/en active Active
- 2014-10-13 CN CN202110888802.0A patent/CN114031676A/zh active Pending
- 2014-10-13 AU AU2014335925A patent/AU2014335925B2/en active Active
- 2014-10-13 DK DK14789350.7T patent/DK3057979T3/da active
- 2014-10-13 US US15/029,399 patent/US10035827B2/en active Active
- 2014-10-13 WO PCT/GB2014/053072 patent/WO2015055991A1/en active Application Filing
- 2014-10-13 JP JP2016522745A patent/JP6691042B2/ja active Active
- 2014-10-13 CN CN202110888795.4A patent/CN114028538A/zh active Pending
- 2014-10-13 BR BR112016008055A patent/BR112016008055A2/pt not_active Application Discontinuation
- 2014-10-13 CN CN201480056203.0A patent/CN105764918B/zh active Active
- 2014-10-13 CA CA2925663A patent/CA2925663A1/en active Pending
- 2014-10-13 ES ES14789350T patent/ES2800599T3/es active Active
- 2014-10-13 EP EP20176131.9A patent/EP3757115A1/en active Pending
-
2018
- 2018-07-06 US US16/028,740 patent/US10774116B2/en active Active
-
2019
- 2019-03-15 AU AU2019201829A patent/AU2019201829B2/en active Active
- 2019-10-28 JP JP2019195276A patent/JP6987825B2/ja active Active
-
2020
- 2020-08-17 US US16/995,344 patent/US20210017239A1/en not_active Abandoned
- 2020-11-25 AU AU2020277188A patent/AU2020277188B2/en active Active
-
2021
- 2021-09-24 US US17/483,920 patent/US20220009974A1/en active Pending
- 2021-12-01 JP JP2021195598A patent/JP7320585B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CN114031676A (zh) | 2022-02-11 |
JP6691042B2 (ja) | 2020-04-28 |
US20160237125A1 (en) | 2016-08-18 |
DK3057979T3 (da) | 2020-06-22 |
EP3757115A1 (en) | 2020-12-30 |
AU2014335925A1 (en) | 2016-04-21 |
JP6987825B2 (ja) | 2022-01-05 |
GB201318170D0 (en) | 2013-11-27 |
WO2015055991A1 (en) | 2015-04-23 |
CN114028538A (zh) | 2022-02-11 |
EP3057979A1 (en) | 2016-08-24 |
JP2022031835A (ja) | 2022-02-22 |
US20190100563A1 (en) | 2019-04-04 |
CA2925663A1 (en) | 2015-04-23 |
AU2019201829A1 (en) | 2019-04-04 |
ES2800599T3 (es) | 2021-01-04 |
AU2014335925B2 (en) | 2019-01-03 |
AU2020277188B2 (en) | 2022-08-25 |
EP3057979B1 (en) | 2020-05-27 |
US10774116B2 (en) | 2020-09-15 |
JP2017501110A (ja) | 2017-01-12 |
CN105764918B (zh) | 2021-08-27 |
AU2019201829B2 (en) | 2020-08-27 |
CN105764918A (zh) | 2016-07-13 |
US20220009974A1 (en) | 2022-01-13 |
JP7320585B2 (ja) | 2023-08-03 |
US10035827B2 (en) | 2018-07-31 |
JP2020039342A (ja) | 2020-03-19 |
AU2020277188A1 (en) | 2020-12-24 |
US20210017239A1 (en) | 2021-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016008055A2 (pt) | Proteínas com usos diagnósticos e terapêuticos | |
DOP2021000005A (es) | Proteínas de unión a pd1 y/o lag3 | |
BR112017018975A2 (pt) | proteínas de fusão compreendendo uma proteína de ligação e um polipeptídeo de interleucina-15 tendo uma afinidade reduzida com il15ra e usos terapêuticos das mesmas | |
CO2018009995A2 (es) | Proteínas de unión y métodos de uso de las mismas | |
BR112016027893A2 (pt) | molécula de ligação triespecífica, e, composição farmacêutica | |
DOP2018000125A (es) | Proteínas de unión a ctla4p | |
CO2019002609A2 (es) | Proteínas de unión recombinantes y sus usos | |
EA201890456A1 (ru) | Новый слитый полипептид, специфичный в отношении lag-3 и pd-1 | |
ECSP14001249A (es) | Inmunoenlazadores dirigidos contra el tnf | |
CO2017009433A2 (es) | Proteínas específicas para pioverdina y pioquelina | |
UA117364C2 (uk) | Похідні аматоксину | |
EA201591839A1 (ru) | Терапевтические пептиды | |
EA201590136A1 (ru) | Искусственные консенсусные альбумин-связывающие домены | |
BR112015029395A2 (pt) | Anticorpos anti-b7-h5 e seus usos | |
MX359449B (es) | Conjugados de anticuerpo fármaco anti-cd70. | |
EA201592143A1 (ru) | Новые бициклические ингибиторы бромодомена | |
BR112016002199A2 (pt) | Proteína anti-garp e usos da mesma | |
CO6670526A2 (es) | Anticuerpos peptídicos beta amiloide anti-n3p glu y usos de los mismos | |
UA117096C2 (uk) | Поліпептид, що зв'язується з c5 комплементу людини | |
BR112018068678A2 (pt) | anticorpos anti-mica | |
UY34101A (es) | Proteínas de unión a antígeno | |
CO2019003951A2 (es) | Proteínas de unión a cd123 y composiciones y métodos relacionados | |
BR112019012796A2 (pt) | proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas | |
BR112016001036A2 (pt) | fusocinas envolvendo citocinas com afinidades de ligação de receptores fortemente reduzida | |
BR112017014615A2 (pt) | proteínas de fusão de multi-direcionamento e seus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |